LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,309,000 | -53.1% | 897,000 | -46.4% | 0.00% | -63.6% |
| Q2 2016 | $2,790,000 | -16.9% | 1,673,000 | -24.0% | 0.01% | -31.2% |
| Q1 2016 | $3,357,000 | -14.1% | 2,202,000 | -13.1% | 0.02% | -11.1% |
| Q4 2015 | $3,910,000 | +45.3% | 2,535,000 | +22.5% | 0.02% | +38.5% |
| Q3 2015 | $2,691,000 | – | 2,069,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 41,855,000 | $69,957,000 | 3.06% |
| Myriad Asset Management Ltd. | 20,000,000 | $33,349,000 | 2.89% |
| TFG Asset Management GP Ltd | 6,000,000 | $10,022,000 | 2.28% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,425,000 | $14,058,000 | 2.18% |
| Opera Trading Capital | 3,700,000 | $6,178,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,575,000 | $37,644,000 | 1.29% |
| Man Investments (CH) AG | 1,000,000 | $1,668,000 | 0.87% |
| Verition Fund Management LLC | 3,200,000 | $5,352,000 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,445,000 | $40,849,000 | 0.62% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,800,000 | $8,014,000 | 0.29% |